DIN 02238873 — AZOPT 1 %
AZOPT is a suspension of Brinzolamide marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Brinzolamide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02238873
- Brand name
- AZOPT
- Active ingredient
- Brinzolamide
- Strength
- 1 %
- Dosage form
- SUSPENSION
- Route
- OPHTHALMIC
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Topical carbonic anhydrase inhibitor (ophthalmic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.